Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Org Chem ; 65(20): 6418-22, 2000 Oct 06.
Artículo en Inglés | MEDLINE | ID: mdl-11052083

RESUMEN

The intramolecular [2 + 2] photocycloaddition of bismaleimides leads to cage diimides 2. Nucleophilic addition on these compounds (NaBH4, RLi, or MeONa) gives rise to various diazatetracyclic 4 and 11 or oxadiazapentacyclic 3 "bowl shaped" alcohols. X-ray analyses of 3c and 11a provide definite structural data concerning these two highly functionalized compounds.

2.
J Pharm Pharmacol ; 52(3): 289-96, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10757416

RESUMEN

This study was designed to test the hypothesis that lipophilic cationic drugs with only roughly similar structures mediate the reversal of multidrug-resistance (MDR) by interacting with membrane phospholipids. The permeation properties of MDR-modulators and non-modulators were studied by quantifying their ability to induce the leakage of Sulphan blue through the membrane of negatively charged unilamellar liposomes. Of the 22 compounds under investigation, only those bearing a net positive electric charge per molecule (z) > or = 0.2 induced dye leakage. All these efficient drugs are well-known MDR-modulators: calcium-channel blockers (propranolol, verapamil, diltiazem and dipyridamole), calmodulin antagonists (clomipramine and thioridazine) and antiparasitic agents (mepacrine, thioacridine derivatives and quinine). The non-modulators tested, including antineoplastic agents and steroids, did not induce any membrane permeation. The permeation process was a co-operative one (1.1 < Hill coefficient < 4.1) and the permeation doses inducing 50% dye leakage (PD50) were 1.9-11.2 mM. The permeation ability of the MDR-modulators (log(1/PD50)) increased significantly with octanol-buffer distributions per unit net electric charge ((logD)/z). The results provide evidence that a complex interplay occurs between the electric charge and the lipophilicity of the MDR-modulators when a dye leakage is induced through model membranes, and probably also when the MDR is reversed in leukaemic cells.


Asunto(s)
Resistencia a Múltiples Medicamentos , Membrana Dobles de Lípidos/química , Antiinflamatorios/química , Antineoplásicos/química , Antiparasitarios/química , Tampones (Química) , Bloqueadores de los Canales de Calcio/química , Fenómenos Químicos , Química Física , Clomipramina/química , Liposomas/química , Octanoles , Permeabilidad , Preparaciones Farmacéuticas/química , Esteroides , Tioridazina/química
3.
J Med Chem ; 42(26): 5448-54, 1999 Dec 30.
Artículo en Inglés | MEDLINE | ID: mdl-10639286

RESUMEN

Series of 9-amino and 9-thioacridines have been synthesized and studied as inhibitors of trypanothione reductase (TR) from Trypanosoma cruzi, the causative agent of Chagas' disease. The compounds are structural analogues of the acridine drug mepacrine (quinacrine), which is a competitive inhibitor of the parasite enzyme, but not of human glutathione reductase, the closest related host enzyme. The 9-aminoacridines yielded apparent K(i) values for competitive inhibition between 5 and 43 microM. The most effective inhibitors were those with the methoxy and chlorine substituents of mepacrine and NH(2) or NHCH(CH(3))(CH(2))(4)N(Et)(2) at C9. Detailed kinetic analyses revealed that in the case of 9-aminoacridines more than one inhibitor molecule can bind to the enzyme. In contrast, the 9-thioacridine derivatives inhibit TR with mixed-type kinetics. The kinetic data are discussed in light of the three-dimensional structure of the TR-mepacrine complex. The conclusion that structurally very similar acridine compounds can give rise to completely different inhibition patterns renders modelling studies and quantitative structure-activity relationships difficult.


Asunto(s)
Acridinas/farmacología , Inhibidores Enzimáticos/farmacología , NADH NADPH Oxidorreductasas/antagonistas & inhibidores , Trypanosoma cruzi/efectos de los fármacos , Acridinas/química , Animales , Inhibidores Enzimáticos/química , Cinética , Espectroscopía de Resonancia Magnética , Relación Estructura-Actividad , Trypanosoma cruzi/enzimología
4.
Anticancer Res ; 18(4C): 3011-5, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9713501

RESUMEN

The antiviral effect of 22 acridine derivatives was studied on the multiplication of herpes simplex virus type 2 (HSV-2) in Vero cells. The inhibitory effect of four acridine derivatives on the multiplication of HSV-2 is emphasised, six other compounds have moderate activity and three only slightly affect the virus multiplication, while nine compounds are inactive. Some of the effective derivatives inhibit the virus replication without any direct effect on the virus particles. However, the mechanism of the antiviral effect is still not known.


Asunto(s)
Acridinas/farmacología , Antivirales/farmacología , Herpesvirus Humano 2/efectos de los fármacos , Replicación Viral/efectos de los fármacos , Animales , Chlorocebus aethiops , Herpesvirus Humano 2/fisiología , Pruebas de Sensibilidad Microbiana , Relación Estructura-Actividad , Células Vero
5.
Anticancer Res ; 18(4C): 3053-8, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9713509

RESUMEN

We studied the effect of thioacridine derivatives on the function of P-glycoprotein in MDR mouse T-lymphoma cell line L5178 and in MDR human leukemia cell line K562/ADR by rhodamine 123 uptake assay. The effect of some selected thioacridines was also investigated on the expression of the mdr1 gene. Expression was analysed by RT-PCR. Two compounds: 3-amino-9-thio-(4'-nitrobenzyl)acridinone and 2,7-dimethoxy-9-thio-(2'-diethylaminoethyl) acridinone were able to block the function of the P-gp, and also to decrease significantly mdr1 gene expression. Because these two derivatives exert their positive effects as reversing agents they could be potential candidate anticancer agents for further investigation. The thioacridines, which do not affect P-gp function, do not affect or increase the expression of mdr1 gene. Our results showed the structure-activity relationships of these compounds, providing a direction for the development of new, more active compounds.


Asunto(s)
Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/efectos de los fármacos , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/fisiología , Acridinas/farmacología , Miembro 1 de la Subfamilia B de Casetes de Unión a ATP/biosíntesis , Animales , Colorantes/farmacocinética , Resistencia a Múltiples Medicamentos , Expresión Génica/efectos de los fármacos , Humanos , Leucemia Mielógena Crónica BCR-ABL Positiva/tratamiento farmacológico , Leucemia Mielógena Crónica BCR-ABL Positiva/metabolismo , Linfoma de Células T/tratamiento farmacológico , Linfoma de Células T/metabolismo , Ratones , Reacción en Cadena de la Polimerasa , ARN Neoplásico/biosíntesis , ARN Neoplásico/metabolismo , Rodamina 123 , Rodaminas/farmacocinética , Transcripción Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA